Researchers at the University of Oxford, working with colleagues in Erlangen, Germany and at the Cleveland Clinic, USA, have developed a new technology based on analysis of computed tomography (CT) coronary angiograms that can flag patients at risk of deadly heart attacks years before they occur.
Fish oil supplements do not prevent heart attacks or strokes in patients with diabetes, according to late breaking results from the ASCEND trial presented today in a Hot Line Session at ESC Congress 2018 and published in the New England Journal of Medicine.
Congratulations to Prof Shoumo Bhattacharya who has secured a \u00a31m programme grant from the British Heart Foundation to further his research on the use of novel anti-inflammatories in cardiovascular disease.
Congratulations to Dr Adam Lewandowski, who has secured a five-year British Heart Foundation Intermediate Basic Science Fellowship to study the impact of premature birth on the heart.
The hearts of people born prematurely are less able to cope with the pressures of exercise in adulthood, according to a new study published in the Journal of the American College of Cardiology and part-funded by the British Heart Foundation and the NIHR Oxford Biomedical Research Centre.
Researchers from the University of Oxford are using artificial intelligence to improve diagnostic accuracy for heart disease. The team hope to roll out the system across the NHS later this year, helping to improve patient outcomes and saving millions is misdiagnoses. The research, led by Prof Paul Leeson and RDM DPhil student Ross Upton (Cardiovascular Clinical Research Facility), took place in the Oxford University Hospitals Foundation Trust and is the basis of spin-out company Ultromics.
![\"\"](\"https://www.cardioscience.ox.ac.uk/news/collaborating-bhf-crm-groups-develop-a-platelet-producing-bone-marrow-bioreactor/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n